Ado-Trastuzumab Emtansine [ado-trastuzumab emtansin]
topical
12
- Terms
-
huN901-DM1
Kadcyla
konjugát T-DM1
trastuzumab emtansin
trastuzumab-DM1
trastuzumab-DM1 konjugát
trastuzumabum emtansinum
-
huN901-DM1
Kadcyla
Trastuzumab Emtansine
Trastuzumab-DM1
Trastuzumab-DM1 Conjugate
Persistent link
https://www.medvik.cz/link/D000080044
Definition
Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
- DUI
- D000080044 MeSH Browser
- CUI
- M0548409
- History note
- 2020 (2010)
- Public note
- 2020; ADO-TRASTUZUMAB EMTANSINE was indexed under TRASTUZUMAB and MAYTANSINE 2012-2019 and under ANTIBODIES, MONOCLONAL 2010-2011
Allowable subheadings
- AD
- administration & dosage 4
- AE
- adverse effects 3
- AN
- analysis
- BL
- blood
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 3
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use 9
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs